The Genetic Dosage Imbalance Linked to Clinical Brain Alterations and Mental Disability in Down Syndrome Could be Targeted for Therapeutics Development
ISSN: 2578-4838
Authors:
Rachidi M*
DOI: 10.23880/mjccs-16000150
Volume 2, Issue 3
Keywords:
View PDF
Read More